EUVIMEDObjevte EUVIMED
Open access · CC BY-NC 4.0

Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention

Jang-Whan Bae

Cardiovascular Prevention and Pharmacotherapy · 2019

DOI: 10.36011/cpp.2019.1.e1 ↗

At a glance

Journal article in Cardiovascular Prevention and Pharmacotherapy, 2019. Written by Jang-Whan Bae. Cited 1 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Cite

APA

Bae, J. (2019). Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention. Cardiovascular Prevention and Pharmacotherapy. https://doi.org/10.36011/cpp.2019.1.e1

Vancouver

Bae J. Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention. Cardiovascular Prevention and Pharmacotherapy. 2019. doi:10.36011/cpp.2019.1.e1

BibTeX
@article{Bae2019,
  author = {Bae, Jang-Whan},
  title = {Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention},
  journal = {Cardiovascular Prevention and Pharmacotherapy},
  year = {2019},
  doi = {10.36011/cpp.2019.1.e1}
}
Start for free →